Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesThe use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
Respiratory Medicine, 06/30/09
Holgate S et al. - Based on clinical trial data analysis, it is recommended that treatment response is evaluated by the physician after 16 weeks of therapy. Treatment should only be continued in responders, i.e. those judged by the physician to have achieved a marked improvement or complete asthma control. Omalizumab is generally well tolerated. Anaphylactic-like reactions are rare and less common than encountered with other biologics.
Related Articles
Reduced FcεRI-Mediated Release of Asthma-Promoting Cytokines and Chemokines from Human Basophils during Omalizumab Therapy
International Archives of Allergy and Immunology, 10/21/09
Relevance Score: 87%
Relationship between pretreatment specific IgE and the response to omalizumab therapy
Allergy, 11/12/09
Relevance Score: 85%
Effects of omalizumab on markers of inflammation in patients with allergic asthma
Allergy, 11/16/09
Relevance Score: 84%
“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
Respiratory Medicine, 10/13/09
Relevance Score: 84%
Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma
Allergy and Asthma Proceedings, 10/12/09
Relevance Score: 83%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: Results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study
The American Journal of Geriatric Pharmacotherapy, 12/20/09
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/20/09
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/20/09
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Doctor-patient communication with people with intellectual disability - a qualitative study
BMC Family Practice, 12/20/09
Influence of sex hormones and phytoestrogens on heart disease in men and women
Women's Health, 12/20/09
Medical waiting periods: imminence, emotions and coping
Women's Health, 12/19/09
Sponsor
Article Search
Sponsor
Sponsor